1
|
Boeer B, Obermoser J, Marx M, Schönfisch B, Grube M, Röhm C, Helms G, Fugunt R, Hartkopf AD, Brucker SY, Hahn M. Ultrasound-guided breast-conserving surgery compared to conventional breast-conserving surgery. ULTRASCHALL IN DER MEDIZIN (STUTTGART, GERMANY : 1980) 2024. [PMID: 38901438 DOI: 10.1055/a-2290-1543] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/22/2024]
Abstract
PURPOSE The goal of breast-conserving surgery is to achieve negative tumor margins, since insufficient marginal distance is associated with more local and distant recurrences. This study investigates whether IOUS (intraoperative ultrasound) can reduce the re-resection rate compared to standard breast surgery, regardless of tumor biology and focality. MATERIALS AND METHODS The present study is a monocentric, prospective, randomized, and non-blinded parallel group study conducted between 7/2015 and 2/2018. Patients with sonographically visible breast cancer were randomized into two study arms: 1) breast-conserving surgery with IOUS; 2) conventional arm. RESULTS 364 patients were included in the study and underwent surgery. Tumor biology, size, and focality were equally distributed in both groups (p = 0.497). The study arms did not differ significantly in the proportion of preoperative wire markings (p= 0.084), specimen weight (p = 0.225), surgery duration (p = 0.849), and the proportion of shavings taken intraoperatively (p = 0.903). Positive margins were present in 16.6% of the cases in the IOUS arm and in 20.8% in the conventional arm (p = 0.347). Re-operation was necessary after intraoperative shavings in 14.4% of cases in the US arm and in 21.3% in the conventional arm (p = 0.100). CONCLUSION Although the present study showed a clear difference in the rate of positive tumor margins with IOUS compared to conventional breast surgery without IOUS, this was not statistically significant in contrast to the current literature. This could be due to the high expertise of the breast surgeons, the precise wire marking, or the fact that the IOUS technique was not standardized.
Collapse
Affiliation(s)
- Bettina Boeer
- Department of Women's Health, University Hospital Tübingen, Tübingen, Germany
| | - Jennifer Obermoser
- Department of Women's Health, University Hospital Tübingen, Tübingen, Germany
| | - Mario Marx
- Department of Women's Health, University Hospital Tübingen, Tübingen, Germany
- ELBLANDKLINIKUM Radebeul, Radebeul, Germany
| | - Birgitt Schönfisch
- Department of Women's Health, University Hospital Tübingen, Tübingen, Germany
| | - Marcel Grube
- Diakonie-Klinikum Schwäbisch Hall, Schwäbisch Hall, Germany
| | - Carmen Röhm
- Department of Women's Health, University Hospital Tübingen, Tübingen, Germany
| | - Gisela Helms
- Department of Women's Health, University Hospital Tübingen, Tübingen, Germany
| | - Regina Fugunt
- Department of Women's Health, University Hospital Tübingen, Tübingen, Germany
| | - Andreas D Hartkopf
- Department of Women's Health, University Hospital Tübingen, Tübingen, Germany
| | - Sara Y Brucker
- Department of Women's Health, University Hospital Tübingen, Tübingen, Germany
| | - Markus Hahn
- Department of Women's Health, University Hospital Tübingen, Tübingen, Germany
| |
Collapse
|
2
|
Cheung BHH, Co M, Lui TTN, Kwong A. Evolution of localization methods for non-palpable breast lesions: a literature review from a translational medicine perspective. TRANSLATIONAL BREAST CANCER RESEARCH : A JOURNAL FOCUSING ON TRANSLATIONAL RESEARCH IN BREAST CANCER 2024; 5:12. [PMID: 38751684 PMCID: PMC11093046 DOI: 10.21037/tbcr-23-49] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/23/2023] [Accepted: 02/27/2024] [Indexed: 05/18/2024]
Abstract
Background and Objective With an increasing number of non-palpable breast lesions detected due to improved screening, accurate localization of these lesions for surgery is crucial. This literature review explores the evolution of localization methods for non-palpable breast lesions, highlighting the translational journey from concept to clinical practice. Methods A comprehensive search of PubMed, Embase, and Scopus databases until September 2023 was conducted. Key Content and Findings Multiple methods have been developed throughout the past few decades. (I) Wire-guided localization (WGL) introduced in 1966, has become a reliable method for localization. Its simplicity and cost-effectiveness are its key advantages, but challenges include logistical constraints, patient discomfort, and potential wire migration. (II) Intraoperative ultrasound localization (IOUS) has shown promise in ensuring complete lesion removal with higher negative margin rates. However, its utility is limited to lesions visible on ultrasound (US) imaging. (III) Breast biopsy marker localization: the use of markers has improved the precision of localization without the need for wire. However, marker visibility remains a challenge despite improvements in their design. (IV) Radioactive techniques: radio-guided occult lesion localization (ROLL) and radioactive seed localization (RSL) offer flexibility in scheduling and improved patient comfort. However, they require close multidisciplinary collaboration and specific equipment due to radioactive concerns. (V) Other wireless non-radioactive techniques: wireless non-radioactive techniques have been developed in recent three decades to provide flexible and patient-friendly alternatives. It includes magnetic seed localization, radar techniques, and radiofrequency techniques. Their usage has been gaining popularity due to their safety profile and allowance of more flexible scheduling. However, their high cost and need for additional training remain a barrier to a wider adoption. Conclusions The evolution of breast lesion localization methods has progressed to more patient-friendly techniques, each with its unique advantages and limitations. Future research on patient-reported outcomes, cosmetic outcomes, breast biopsy markers and integration of augmented reality with breast lesion localization are needed.
Collapse
Affiliation(s)
- Billy Ho Hung Cheung
- Division of Breast Surgery, Department of Surgery, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China
| | - Michael Co
- Division of Breast Surgery, Department of Surgery, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China
| | | | - Ava Kwong
- Division of Breast Surgery, Department of Surgery, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China
- Department of Surgery, Hong Kong Sanatorium & Hospital, Hong Kong, China
| |
Collapse
|
3
|
Chakedis JM, Tang A, Savitz A, Lyon LL, Palacios PE, Vuong B, Kavanagh MA, Kuehner GE, Chang SB. Economic Impact of Reducing Reexcision Rates after Breast-Conserving Surgery in a Large, Integrated Health System. Ann Surg Oncol 2022; 29:6288-6296. [PMID: 35904654 DOI: 10.1245/s10434-022-12127-6] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2022] [Accepted: 06/12/2022] [Indexed: 11/18/2022]
Abstract
BACKGROUND Reexcision after breast-conserving surgery (BCS) is costly for patients, but few studies have captured the economic burden to a healthcare system. We quantified operating room (OR) charges as well as OR time and then modeled expected savings of a reexcision reduction initiative. METHODS We performed a retrospective cohort review of all breast cancer patients with BCS between January 1, 2016 and December 31, 2020. Operating room charges of disposable supplies and implants as well as operative time were calculated. RESULTS During the 5-year period, the 8804 patients who underwent BCS, 1628 (18.5%) required reexcision. The reexcision cohort was younger (61 vs. 64 years, p < 0.001), more likely to have ductal carcinoma in situ (DCIS) (23.7% vs. 15.2%, p < 0.001), and had larger tumors (T1+T2 73.2% vs. 83.1%, p < 0.001). Reexcision costs represented 39% of total costs, the cost per patient for surgery was fourfold higher for reexcision patients. Reexcision operations comprised 14% of total operating room (OR) time (1848 of 13,030 hours). The reexcision rate for 54 surgeons varied from 7.2-39.0% with 46% (n = 25) having a reexcision rate >20%. A model simulating reducing reexcision rates to 20% or below for all surgeons reduced the reexcision rate to 16.2% overall. Using per procedure data, the model predicted a decrease in reexcision operations by 18% (327 operations), OR costs by 14% ($287,534), and OR time by 11% (204 hours). CONCLUSIONS Reexcision after BCS represents 39% of direct OR costs and 14% of OR time in our healthcare system. Modest improvements in surgeon reexcision rates may lead to significant economic and OR time savings.
Collapse
Affiliation(s)
- Jeffery M Chakedis
- Department of General Surgery, The Permanente Medical Group (TPMG), Oakland, CA, USA
| | - Annie Tang
- Department of Surgery, University of California San Francisco, East Highland Hospital, Oakland, CA, USA
| | - Alison Savitz
- Department of General Surgery, The Permanente Medical Group (TPMG), Oakland, CA, USA
| | - Liisa L Lyon
- Kaiser Permanente Northern California Division of Research, Oakland, CA, USA
| | - Patricia E Palacios
- Enterprise Business Services, Kaiser Foundation Health Plan, Oakland, CA, USA
| | - Brooke Vuong
- Department of General Surgery, The Permanente Medical Group (TPMG), Oakland, CA, USA
| | - Maihgan A Kavanagh
- Department of General Surgery, The Permanente Medical Group (TPMG), Oakland, CA, USA
| | - Gillian E Kuehner
- Department of General Surgery, The Permanente Medical Group (TPMG), Oakland, CA, USA
| | - Sharon B Chang
- Department of General Surgery, The Permanente Medical Group (TPMG), Oakland, CA, USA. .,Department of Surgery, Kaiser Permanente Medical Center Fremont, Fremont, CA, USA.
| | | |
Collapse
|
4
|
Chakedis JM, Tang A, Kuehner GE, Vuong B, Lyon LL, Romero LA, Raber BM, Mortenson MM, Shim VC, Datrice-Hill NM, McEvoy JR, Arasu VA, Wisner DJ, Chang SB. Implementation of Intraoperative Ultrasound Localization for Breast-Conserving Surgery in a Large, Integrated Health Care System is Feasible and Effective. Ann Surg Oncol 2021; 28:5648-5656. [PMID: 34448055 PMCID: PMC8418593 DOI: 10.1245/s10434-021-10454-8] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2021] [Accepted: 05/25/2021] [Indexed: 12/20/2022]
Abstract
BACKGROUND Intraoperative ultrasound (IUS) localization for breast cancer is a noninvasive localization technique. In 2015, an IUS program for breast-conserving surgery (BCS) was initiated in a large, integrated health care system. This study evaluated the clinical results of IUS implementation. METHODS The study identified breast cancer patients with BCS from 1 January to 31 October 2015 and from 1 January to 31 October 2019. Clinicopathologic characteristics were collected, and localization types were categorized. Clinical outcomes were analyzed, including localization use, surgeon adoption of IUS, day-of-surgery intervals, and re-excision rates. Multivariate logistic regression analysis was performed to evaluate predictors of re-excision. RESULTS The number of BCS procedures increased 23%, from 1815 procedures in 2015 to 2226 procedures in 2019. The IUS rate increased from 4% of lumpectomies (n = 79) in 2015 to 28% of lumpectomies (n = 632) in 2019 (p < 0.001). Surgeons using IUS increased from 6% (5 of 88 surgeons) in 2015 to 70% (42 of 60 surgeons) in 2019. In 2019, 76% of IUS surgeons performed at least 25% of lumpectomies with IUS. The mean time from admission to incision was shorter with IUS or seed localization than with wire localization (202 min with IUS, 201 with seed localization, 262 with wire localization in 2019; p < 0.001). The IUS re-excision rates were lower than for other localization techniques (13.6%, vs 19.6% for seed localization and 24.7% for wire localization in 2019; p = 0.006), and IUS predicted lower re-excision rates in a multivariable model (odds ratio [OR], 0.59). CONCLUSIONS In a high-volume integrated health system, IUS was adopted for BCS by a majority of surgeons. The use of IUS decreased the time from admission to incision compared with wire localization, and decreased re-excision rates compared with other localization techniques.
Collapse
Affiliation(s)
- Jeffery M Chakedis
- Department of General Surgery and Radiology, The Permanente Medical Group (TPMG), Oakland, CA, USA
| | - Annie Tang
- Department of Surgery, University of California San Francisco, East Bay-Highland Hospital, Oakland, CA, USA
| | - Gillian E Kuehner
- Department of General Surgery and Radiology, The Permanente Medical Group (TPMG), Oakland, CA, USA
| | - Brooke Vuong
- Department of General Surgery and Radiology, The Permanente Medical Group (TPMG), Oakland, CA, USA
| | - Liisa L Lyon
- Kaiser Permanente Northern California Division of Research, Oakland, CA, USA
| | - Lucinda A Romero
- Department of General Surgery and Radiology, The Permanente Medical Group (TPMG), Oakland, CA, USA
| | - Benjamin M Raber
- Department of General Surgery and Radiology, The Permanente Medical Group (TPMG), Oakland, CA, USA
| | - Melinda M Mortenson
- Department of General Surgery and Radiology, The Permanente Medical Group (TPMG), Oakland, CA, USA
| | - Veronica C Shim
- Department of General Surgery and Radiology, The Permanente Medical Group (TPMG), Oakland, CA, USA
| | - Nicole M Datrice-Hill
- Department of General Surgery and Radiology, The Permanente Medical Group (TPMG), Oakland, CA, USA
| | - Jennifer R McEvoy
- Department of General Surgery and Radiology, The Permanente Medical Group (TPMG), Oakland, CA, USA
| | - Vignesh A Arasu
- Department of General Surgery and Radiology, The Permanente Medical Group (TPMG), Oakland, CA, USA
| | - Dorota J Wisner
- Department of General Surgery and Radiology, The Permanente Medical Group (TPMG), Oakland, CA, USA
| | - Sharon B Chang
- Department of General Surgery and Radiology, The Permanente Medical Group (TPMG), Oakland, CA, USA. .,Department of Surgery, Kaiser Permanente Fremont Medical Center, Fremont, CA, USA.
| | | |
Collapse
|
5
|
Fama' F, Di Maria A, Cicciu' M, Buccheri G, Gioffre'-Florio M, Benvenga S, Sindoni A. Intraoperative sonography for nonpalpable breast lesions: Additional indications for a consolidate technique. Breast J 2019; 26:479-483. [PMID: 31524310 DOI: 10.1111/tbj.13575] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2019] [Revised: 08/15/2019] [Accepted: 08/16/2019] [Indexed: 11/29/2022]
Abstract
This prospective study evaluated the intraoperative ultrasound scan (IUSS) for nonpalpable breast lesions' detection. A total of 108 consecutive female patients underwent surgery using IUSS: Frozen sections demonstrated clear margins in 95.5% of neoplastic patients. Only four (4.5%) patients underwent local re-excision in the same operation. IUSS demonstrated to be quick, accurate, useful, effective, and safe for the intraoperative management of neoplastic nonpalpable breast lesions when performed by a surgeon who has undergone US training, particularly for people in whom alternative approaches can show some limitations due to contraindications or because of scheduling constraints, costs, and patient discomfort.
Collapse
Affiliation(s)
- Fausto Fama'
- Department of Human Pathology in Adulthood and Childhood "G. Barresi", University Hospital of Messina, Italy
| | - Alessandra Di Maria
- Department of Ophthalmology, Humanitas Clinical and Research Center, Rozzano/Milano, Italy
| | - Marco Cicciu'
- Department of Biomedical and Dental Sciences and of Morphological and Functional Images, University Hospital of Messina, Italy
| | - Giancarlo Buccheri
- Department of Human Pathology in Adulthood and Childhood "G. Barresi", University Hospital of Messina, Italy
| | - Maria Gioffre'-Florio
- Department of Human Pathology in Adulthood and Childhood "G. Barresi", University Hospital of Messina, Italy
| | - Salvatore Benvenga
- Department of Clinical and Experimental Medicine, University Hospital of Messina, Italy
| | - Alessandro Sindoni
- Department of Public Health and Infectious Diseases, Sapienza University of Rome, Italy
| |
Collapse
|